Medicamento contra diabetes revela ser prometedor para bajar de peso
MARTES, 17 de octubre de 2023 (HealthDay News) — Un nuevo ensayo demuestra el poder del medicamento para la diabetes Mounjaro en la lucha contra la obesidad, ayudando a las personas que usaron el medicamento a perder alrededor de 60 libras (aproximad…
Learn MoreIn Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 Pounds
MONDAY, Oct. 16, 2023 (HealthDay News) — A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.”In this study, people who added tirzepatide [Mounjaro] to diet …
Learn MoreWeight Loss-Driven Remission of Prediabetes Tied to Lower Type 2 Diabetes Risk
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Weight loss-driven remission of prediabetes protects against type 2 diabetes and is associated with better kidney and vascular function, according to a study published online Sept. 25 in The Lancet Diabetes…
Learn MoreWegovy, Ozempic Help Folks Lose Weight, But How?
TUESDAY, Oct. 10, 2023 (HealthDay News) — As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution.The drugs are not well-tolerated by everyone strugglin…
Learn MoreEstudio confirma riesgo de problemas gastrointestinales en consumidores de Wegovy y Ozempic
VIERNES, 6 de octubre de 2023 (HealthDay News) — Aunque muchos han elogiado los poderes de populares medicamentos para perder peso como Wegovy y Ozempic, una nueva investigación confirma que estos medicamentos pueden desencadenar efectos secundarios …
Learn MoreGI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss
FRIDAY, Oct. 6, 2023 (HealthDay News) — Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel obstruction compared with use of bupropion-naltrexone, acco…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreDurable Reductions in HbA1c, Body Weight Seen With Semaglutide
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Use of once-weekly subcutaneous semaglutide is associated with sustained reductions in hemoglobin A1c (HbA1c) and body weight, according to a study presented at the annual meeting of the European Association…
Learn More